The present invention relates to generating cartilage by means of a formulation which is produced by the exosomes that are released by the cells isolated from septal cartilage to the medium. The objective of the present invention is to generate a cartilage which can be used in the treatment of cartilage tissue defects, such as osteoarthritis or arthrosis, since it induces cartilage formation and also suppresses the inflammatory response.
展开▼
